FORT LAUDERDALE, Fla. — Early pars plana vitrectomy may be a low-cost, definitive treatment for patients with proliferative diabetic retinopathy, according to a speaker at the Retina World Congress.
Francesco Boscia, MD, said the indications for early vitrectomy have traditionally been in patients at high risk for threatened vision, including those with dense premacular vitreous hemorrhage, traction macular detachment and other complications.
“This was mainly due to the risk of surgery in the era of 20 gauge and the cost related to possibly multiple surgical approaches,” he